Kenneth C. Frazier is chairman of the board and chief executive officerof Merck & Co., Inc.
Previously, Mr. Frazier served as president of Merck, with responsibility for the company’s three major divisions: Global Human Health, Merck’s pharmaceutical and vaccine business; Merck Manufacturing Division, Merck’s manufacturing and supply division; and Merck Research Laboratories, Merck’s research organization.
Mr. Frazier has held a broad range of senior management positions since joining Merck in 1992 as vice president, general counsel and secretary of the Astra Merck Group. He was elected vice president of public affairs in 1994 and in 1997, assumed the additional responsibilities of assistant general counsel, corporate staff. Mr. Frazier was promoted to vice president and deputy general counsel in January 1999. In December 1999, he became senior vice president and general counsel. In this role, he oversaw Merck’s legal and public affairs functions and The Merck Company Foundation. In November 2006, he was promoted to executive vice president and general counsel. Mr. Frazier served as executive vice president and president, Global Human Health, from 2007 to May 2010, when he became Merck president.
Prior to joining Merck & Co., Mr.Frazier was a Partner in the Litigation Department of Drinker Biddle & Reath, 1978-1992.
Mr.Frazier is a Board Member, Exxon Mobil Corporation, Board Member, Pennsylvania State University, Board Member, Cornerstone Christian Academy, Board Member, Ithaka (a non-profit academic technology organization), Member, Council of the American Law Institute, Member, American Bar Association, Member, Council on Foreign Relations
Mr.Frazier holds a J.D., Harvard Law School, 1978 and a B.A., Political Science, Pennsylvania State University, 1975.
